No Data
No Data
Dai Seki, Aki Iijima Industry, Carra, Next Stage (6th)
※The above Calendar is only a plan and may change due to the company's circumstances.---------------------------------------January 6 (Monday) <1712> Dai Sekis <1997> Aki Iijima Industries <2789> Karura <3186> Nextage <7611> Haide Hidaka <9793> Dai Sekis-------------------------------
Express News | Sankyo Tateyama -Revises 6-Mth Group Net Forecast to Profit 50 Mln Yen From Profit 1.00 Bln Yen (-95.0%)
Sankyo Tateyama: (Correction/Numerical Data Correction) Partial Corrections to the “Notice Concerning Revision of Earnings Forecasts”
December 27 [Today's Investment Strategy]
[Selected Stocks by Fisco] 【Material Stocks】 Kaken Pharmaceutical <4521> 4174 yen (12/26) Main products include the nail fungus treatment 'Klenafin' and the joint function improvement drug 'Alts'. The company announced the signing of a contract granting Johnson & Johnson exclusive rights for the development, manufacturing, and commercialization globally of the 'STAT6 Program', which is being developed as a next-generation oral treatment for type 2 inflammatory diseases (such as atopic dermatitis and asthma).
Focus on DeNA and Kaken Pharmaceutical, while Oisix and Sankyo Tateyama may be sluggish.
In the US stock market on the 26th, the Dow Jones Industrial Average rose by $28.77 to 43,325.80, the Nasdaq Composite Index fell by 10.77 points to 20,020.36, and the Chicago Nikkei 225 Futures were up by 210 yen compared to Osaka daytime at 39,700 yen. The exchange rate was 1 dollar = 158.00-10 yen. In today's Tokyo market, Kusuri no Aoki <3549> saw an increase in operating profit of 85.5%, expanding from 10.2% growth in the first quarter, and the performance of its gaming business for the fiscal year ending in March 2025 is expected to see an increase in both revenue and profit compared to the previous period.
Okaya Steel Corporation, operating profit for Q3 increased by 4.6% to 25.8 billion yen.
Okaya Steel <7485> announced that for the third quarter of the fiscal year ending February 2025, revenue was 827.9 billion 66 million yen, an increase of 1% compared to the same period last year, and operating profit was 25.8 billion 93 million yen, an increase of 4.6%. The Iron & Steel division performed well in the manufacturing sector, but related to construction materials saw a decrease. Overseas, revenue decreased in Asia but increased in Europe and the U.S. The Electronics division saw increases in information Infrastructure, but a decrease in automotive Components and FA related products. The Nonferrous Metals division faced rising material prices, along with an increase in environmentally friendly materials.